Advanced Persistent Threats Apts

Tim Walbert joined Horizon in June 2008 as president and chief executive officer and has served as chairman of the company’s board of administrators since 2010. Before joining Horizon, he served as president, chief executive officer and director of IDM Pharma Inc., a public biopharmaceutical company which was acquired by Takeda America Holdings Inc., or Takeda, in June 2009. Before IDM, Walbert served as government vp, commercial operations at NeoPharm Inc., a public biopharmaceutical firm. From 2001 to 2005, he served as divisional vp and general supervisor, immunology, at Abbott, now AbbVie, main the global growth and launch of the multi-indication biologic HUMIRA, and served as divisional vice chairman, global cardiovascular strategy.

Khaterine William

Leave a Reply

Back to top